# HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome

> **NCT04591990** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 380 (estimated)

## Conditions studied

- Postresuscitation Syndrome

## Interventions

- **DRUG:** Administration of AVP
- **DRUG:** Administration of placebo AVP
- **DRUG:** Administration of placebo hydrocortisone
- **DRUG:** Administration of hydrocortisone

## Key facts

- **NCT ID:** NCT04591990
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-27
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591990, "HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04591990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*